Table 2.

The association of different CDK5RAP3 and UFM1 expression levels in gastric cancer tissues with clinicopathological factors.

Variables	Total	CDK5RAP3 and UFM1 low expression	CDK5RAP3 and/or UFM1 high expression	χ2	P
Gender
Male	98	65	33	0.462	0.497
Female	26	17	9
Age (years)
>60	47	21	26	0.400	0.527
≤ 60	77	61	16
BMI (kg/m2)
>25	23	19	4	9.666	0.002
≤ 25	101	63	38
Tumor size (cm)
>5	48	31	17	4.972	0.026
≤5	76	51	25
Tumor location
Lower 1/3	55	33	22	3.848	0.146
Middle 1/3	23	18	5
Upper 1/3	46	31	15
Borrmann type
I+II	27	20	7	1.146	0.284
III+IV	97	62	35
Differentiation type
Undifferentiated	78	54	24	3.045	0.081
Differentiated	46	28	18
pT stage
T1+ T2	18	9	9	7.965	0.005
T3+ T4	106	73	33
pN stage
N0	17	9	8	16.236	0.001
N1	20	12	8
N2	42	27	15
N3	45	34	11
TNM stage
I+II	39	20	19	9.422	0.002
III	85	62	23
Vessel invasion
Negative	80	54	26	0.001	0.981
Positive	44	28	16